Buckinghamshire, UK-based Ashley Communications marked two decades of medical communications consulting at the close of 2016, a year that saw the firm strengthen its position with several new business wins.
The consultancy is set to put its expertise in strategic counsel, digital and patient engagement, clinical trial communications and opinion leader development to use for eight new clients this year.
Among this number are big pharma firms Abbvie, Allergan and Merck & Co, as well as UK-based Abbott Diagnostics, opioid addiction specialist Indivior, Tokyo-based Otsuka, detection and informatics specialist Perkin Elmer and Torax Medical, a gastroenterology-focused firm.
Ashley Communications chairman Chrissie Ashley, said: “Our key objective for 2016 was to broaden our client base and to fully utilise the therapeutic experience we have within our agency.
“We are delighted with the results, which put us in a strong position starting 2017.
“We also believe our partnership with Southwood research, which was announced earlier this year, has contributed to our success by providing a truly combined service that really adds value to the services we offer our clients.”